Vivani Medical Inc (Vivani Medical), formerly Second Sight Medical Products Inc, is a biopharmaceutical company focuses on developing miniature, long-term drug implants to address medication non-adherence and tolerability in chronic disease treatment. The company's pipeline products include products include NPM-115, NPM-119, NPM-139 and OKV-119. NPM-115 and NPM-139 are for the treatment of human obesity. NPM-119 is for human type II diabetes. OKV-119 targets feline pre-diabetes and diabetes. It markets its products under Vivani and NanoPortal. The company operates through its medical centers located across the US. Vivani Medical is headquartered in Alameda, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Vivani Medical Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Vivani Medical Inc Company Overview
- Vivani Medical Inc Company Snapshot
- Vivani Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Vivani Medical Inc - Pipeline Analysis Overview
- Vivani Medical Inc - Key Facts
- Vivani Medical Inc - Major Products and Services
- Vivani Medical Inc Pipeline Products by Development Stage
- Vivani Medical Inc Ongoing Clinical Trials by Trial Status
- Vivani Medical Inc Pipeline Products Overview
- Argus I Retinal Stimulation System
- Argus I Retinal Stimulation System Product Overview
- Argus III Retinal Stimulation System
- Argus III Retinal Stimulation System Product Overview
- NanoPortal Capsule
- NanoPortal Capsule Product Overview
- NPM-115
- NPM-115 Product Overview
- NPM-115 Clinical Trial
- NPM-119
- NPM-119 Product Overview
- NPM-119 Clinical Trial
- NPM-139
- NPM-139 Product Overview
- Orion Cortical Visual Prosthesis System
- Orion Cortical Visual Prosthesis System Product Overview
- Orion Cortical Visual Prosthesis System Clinical Trial
- Stroke Recovery System
- Stroke Recovery System Product Overview
- Vivani Medical Inc - Key Competitors
- Vivani Medical Inc - Key Employees
- Vivani Medical Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Vivani Medical Inc, Recent Developments
- Sep 04, 2024: Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant
- Feb 28, 2024: Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic/Wegovy and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio
- Sep 05, 2023: Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10
- Jul 11, 2023: Vivani Medical Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion Visual Cortical Prosthesis System
- Jun 14, 2023: Vivani Medical to Participate in Panel Discussion at the Healthcare Virtual Conference Presented by Maxim Group and Hosted by M-Vest
- Apr 04, 2023: Vivani Medical announces $1 million NIH grant funding to support Cortigent’s ongoing Orion clinical study
- Oct 17, 2022: Vivani Medical to Present at the ThinkEquity Investor Conference
- Jul 29, 2022: Second Sight Medical Products Announces Shareholder Approval for Proposed Merger with Nano Precision Medical, Inc. and other Results of 2022 Annual Meeting
- Jul 18, 2022: Second Sight Medical Products announces year four NIH funding of its orion study
- Aug 04, 2021: Second Sight Medical Products receives grant from NIH for the study of Visual Cortical Prosthesis system
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Vivani Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Vivani Medical Inc Pipeline Products by Equipment Type
- Vivani Medical Inc Pipeline Products by Indication
- Vivani Medical Inc Ongoing Clinical Trials by Trial Status
- Vivani Medical Inc, Key Facts
- Vivani Medical Inc, Major Products and Services
- Vivani Medical Inc Number of Pipeline Products by Development Stage
- Vivani Medical Inc Pipeline Products Summary by Development Stage
- Vivani Medical Inc Ongoing Clinical Trials by Trial Status
- Vivani Medical Inc Ongoing Clinical Trials Summary
- Argus I Retinal Stimulation System - Product Status
- Argus I Retinal Stimulation System - Product Description
- Argus III Retinal Stimulation System - Product Status
- Argus III Retinal Stimulation System - Product Description
- NanoPortal Capsule - Product Status
- NanoPortal Capsule - Product Description
- NPM-115 - Product Status
- NPM-115 - Product Description
- NPM-115 - A Study to Evaluate the Efficacy of NPM-115 for the Treatment of Obesity and Chronic Weight Management
- NPM-119 - Product Status
- NPM-119 - Product Description
- NPM-119 - A Randomized, Parallel-Group Study to Assess the Safety, Tolerability, and Pharmacokinetics of Exenatide Implant
- NPM-139 - Product Status
- NPM-139 - Product Description
- Orion Cortical Visual Prosthesis System - Product Status
- Orion Cortical Visual Prosthesis System - Product Description
- Orion Cortical Visual Prosthesis System - Early Feasibility Study of the Orion Visual Cortical Prosthesis System
- Orion Cortical Visual Prosthesis System - Successful Implantation and Activation of Wireless Visual Cortical Stimulator in First Human Subject
- Stroke Recovery System - Product Status
- Stroke Recovery System - Product Description
- Vivani Medical Inc, Key Employees
- Vivani Medical Inc, Subsidiaries
- Glossary
- Vivani Medical Inc Pipeline Products by Equipment Type
- Vivani Medical Inc Pipeline Products by Development Stage
- Vivani Medical Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AngioDynamics Inc
- Dynatronics Corp
- Utah Medical Products Inc
- Iridex Corp
- STAAR Surgical Co
